Schonfeld Strategic Advisors LLC Galapagos Nv Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $2.67 Million - $3.66 Million	-51,082 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $392,905 - $524,436	7,656 Added 17.63%	51,082 $3.17 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $2.04 Million - $2.48 Million	43,426 New	43,426 $2.39 Million
Q3 2021 Nov 16, 2021	SELL	$52.17 - $70.2 $2.22 Million - $2.98 Million	-42,510 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $2.37 Million - $2.86 Million	-34,365 Reduced 44.7%	42,510 $2.93 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $4.03 Million - $5.93 Million	52,975 Added 221.65%	76,875 $5.93 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $1.26 Million - $1.93 Million	12,990 Added 119.07%	23,900 $2.37 Million
Q3 2020 Nov 16, 2020	BUY	$122.47 - $213.56 $1.34 Million - $2.33 Million	10,910 New	10,910 $2,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.